What is Inogen's market cap?

Inogen (INGN) has a market capitalization of $170.8M and trades on NASDAQ.

What is Inogen's revenue and profitability?

Inogen generated $351.5M in trailing twelve-month revenue with a net loss of $24.9M, representing a net margin of -7.1%. Gross margin stands at 52.8%, with free cash flow of -$20.6M. These figures are based on the Q1 2026 filing.

Who are Inogen's competitors?

Inogen's key competitors include Viemed Healthcare, Inc., ResMed Inc., AdaptHealth Corp., and others. These companies compete in similar markets and product categories.

Who does Inogen partner with?

Inogen's notable partners include Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (Yuwell), Foxconn.

What subsidiaries does Inogen have?

Inogen's subsidiaries include Inogen Europe B.V., Physio-Assist SAS, New Aera, Inc..

Where is Inogen headquartered?

Inogen is headquartered in United States of America and employs approximately 834 people. It has been publicly traded since 2014.

Inogen

INGN

Inogen Inc is a medical technology company specializing in innovative respiratory health solutions for patients with chronic conditions like COPD and bronchiectasis.

Market cap

$170.84M-3.0%

Revenue$351.5M+3.4%

Net income-$24.9M+9.4%

Free cash flow-$20.6M-81.5%

EPS (diluted)-$0.92+20.0%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$85.1MBeat by $2.8M EPS-$0.30Miss by $0.06

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$95.2M

EPS estimate-$0.17

Financials

Q1 2026

Income statement

See full

Revenue$85.1M+3.4%

Gross profit$44.9M+1.7%

Operating income-$9.3M-21.9%

Net income-$8.3M-34.8%

EPS (diluted)-$0.30-20.0%

Balance sheet

See full

Cash & equivalents$93.1M-21.7%

Total debt$16.9M-11.9%

Total equity$182.9M-7.6%

Total assets$285.9M-7.3%

Cash flow

See full

Operating cash flow-$6.7M+60.2%

CapEx$210.0K-28.1%

Free cash flow-$6.9M+59.6%

Valuation & ratios

Valuation

See full

Market cap$170.84M-3.0%

Enterprise value$94.66M-3.3%

P/S0.5×0.0×

Profitability

See full

Gross margin52.8%-2.6pp

Operating margin-9.1%-0.8pp

Net margin-7.1%-0.8pp

Returns & leverage

See full

Return on equity-13.1%-0.9pp

Debt / equity0.1×0.0×

Current ratio3.1×0.0×

Competitors

By market cap

ResMed$29.5B-26.5%

Philips$24.3B+2.4%

AdaptHealth$1.5B+15.2%

Savara$1.1B+142%

Viemed Healthcare, Inc.$464.6M+88.7%

Inogen$170.8M-6.4%

Pulmonx Corporation$51.5M-58.6%

Vivos Therapeutics, Inc.$5.6M-79.9%

By revenue growth

Viemed Healthcare, Inc.+23.1%

ResMed+10.3%

Inogen+3.4%

AdaptHealth+1.2%

Pulmonx Corporation+1.2%

By net margin

ResMed27.44%+1.3pp

Viemed Healthcare, Inc.5.2%-0.1pp

AdaptHealth-2.42%-5.0pp

Inogen-7.08%+1.0pp

Pulmonx Corporation-60.09%+5.2pp

Savara-19,305.06%—

Profile

Inogen Inc is a medical technology company specializing in innovative respiratory health solutions for patients with chronic conditions like COPD and bronchiectasis. The company develops and manufactures portable and stationary oxygen concentrators designed to improve patient mobility and quality of life by reducing reliance on traditional oxygen tank deliveries. Its value proposition centers on a direct-to-consumer model and proprietary pulse-dose technology that enables 24/7 oxygen therapy in a lightweight, ambulatory format.

Competitive position

A leading provider of portable oxygen concentrators known for a unique direct-to-consumer rental strategy and proprietary Intelligent Delivery Technology.

GeographiesUnited States, Europe, Asia-Pacific

Customer segmentsChronic respiratory patients, Home medical equipment providers, Medicare and private insurance beneficiaries

Business modelManufacturing, Direct-to-Consumer, Rental and Leasing, B2B Distribution

SuppliersSingle-source component suppliers, Contract manufacturers, Electronic component providers, Sieve bed and compressor manufacturers

CustomersMedicare and Medicaid, Private insurance payors, Home medical equipment (HME) providers, Individual respiratory patients

CountryUnited States of America

Listed2014

Employees834.0

CEOKevin R. Smith

SectorHealthcare

IndustryMedical - Devices

Websiteinogen.com

FilingsSEC EDGAR

Ask your AI about Inogen.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inogen's market cap?: Inogen (INGN) has a market capitalization of $170.8M and trades on NASDAQ.
What is Inogen's revenue and profitability?: Inogen generated $351.5M in trailing twelve-month revenue with a net loss of $24.9M, representing a net margin of -7.1%. Gross margin stands at 52.8%, with free cash flow of -$20.6M. These figures are based on the Q1 2026 filing.
Who are Inogen's competitors?: Inogen's key competitors include Viemed Healthcare, Inc., ResMed Inc., AdaptHealth Corp., and others. These companies compete in similar markets and product categories.
Who does Inogen partner with?: Inogen's notable partners include Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (Yuwell), Foxconn.
What subsidiaries does Inogen have?: Inogen's subsidiaries include Inogen Europe B.V., Physio-Assist SAS, New Aera, Inc..
Where is Inogen headquartered?: Inogen is headquartered in United States of America and employs approximately 834 people. It has been publicly traded since 2014.